In transgenic Drosophila expressing human tau, RNAi-mediated knockdown of Milton or Miro enhanced tau-induced neurodegeneration and increased tau phosphorylation at the AD-related site Ser262. The gene discussed is MAPT; the disease is Alzheimer disease.